Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma.
Kedmi M, Ribakovsy E, Benjamini O, Schiby G, Barshack I, Raskin S, Eshet Y, Mehr R, Horowitz N, Gurion R, Goldschmidt N, Perry C, Levi I, Aviv A, Herzog-Tzarfati K, Nagler A, Avigdor A.
Kedmi M, et al. Among authors: perry c.
Hematol Oncol. 2024 Nov;42(6):e70001. doi: 10.1002/hon.70001.
Hematol Oncol. 2024.
PMID: 39572395
Clinical Trial.